Navigation Links
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Date:1/25/2008

NDC NUMBERS 0641-2440-45, 0641-2440-41, 0641-2450-45 and 0641-2450-41; LOTS: 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074,

107111

DEERFIELD, Ill., Jan. 25 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation has announced the voluntary recall of nine lots of heparin sodium injection 1000 units/mL 10mL and 30mL multi-dose vials. The company began recalling the lots on January 17, 2008 as a precautionary measure due to an increase in the number of reports of adverse patient reactions that may be associated with the product. Baxter is conducting a thorough investigation of these reports to identify the cause of the increase in allergic-type reactions.

Adverse patient reactions have included: stomach pain or discomfort, nausea, vomiting, diarrhea, decreased or low blood pressure, chest pain, fast heart rate, dizziness, fainting, unresponsiveness, shortness of breath, feeling your heart beat strong or fast, drug ineffectiveness, burning sensation, redness or paleness of skin, abnormal sensation of the skin, mouth or lips, flushing, increased sweating, decreased skin sensitivity, headache, feeling unwell, restlessness, watery eyes, throat swelling, thirst and difficulty opening the mouth. Some of these reactions may be severe or life threatening.

Heparin is a prescription, injectable blood anticoagulant (also called a blood thinner). The 1,000 units/mL multi-dose vials are primarily used for hemodialysis and cardiac invasive procedures. To date, the company has not observed a significant increase in adverse event reports occurring with any other of its heparin presentations.

Customers have been instructed to discontinue use and segregate the recalled product from the rest of their inventory. Customers should then contact Baxter to arrange for return and replacement product. Customers with recalled product purchased indirectly should contact their wholesaler or distributor for re
'/>"/>

SOURCE Baxter Healthcare Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Baxter International Fourth Quarter 2007 Financial Results Conference Call
2. Baxter Announces FDA Approval of GELFOAM(R) Plus Hemostasis Kit
3. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
4. Baxter Kidney Patient Education Program Celebrates Tenth Anniversary
5. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
6. Baxter and Novation Sign Multi-Year Contract Extension Valued at Over $200 Million for Medication Delivery Products
7. Baxter Named to Dow Jones Sustainability Index for Ninth Consecutive Year
8. Baxter and Halozyme Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
9. Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients
10. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
11. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., PARIS, November 27 /PRNewswire-FirstCall/...l to market Oralair(R) in both adults and children...the first country where,Oralair(R) has been market...lair(R) is now registered in Austria, Belgium, Bul..., Germany, Greece, Hungary, Ireland, Italy,Latvia...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotech...virus, genomic data from the 1918 pandemic through...rent H1N1 pandemic, today issued its latest bioche...at the lethality of the H1N1 ("Swine Flu") virus h...the virus,s current outbreak in the spring of 2009...
(Date:11/25/2009)... , BEIJING, Nov. 25 /PRNewswire-Asia/...er and provider of vaccines, announced today that ...blish Sinovac (Dalian) Vaccine,Technology Co., Ltd... produce,and commercialize human-use vaccines. Sin...in developing and commercializing world-class vacc...
(Date:11/24/2009)... , HOUSTON, Nov. 24 /PRNewswire-FirstCall/ -...r of electrical and communications systems and ser...al markets, announced today that its commercial bu...attan Torcon JV to install the electrical systems ... facility at the U.S. Army Medical Research Instit...
Breaking Biology Technology:STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...launch..., WAYLAND, Mass., March 20 Tourtellotte...clinical trials software, announces the,launch of ...orm for phase,II-IV studies. Trident,s unique para... of legacy IVRS technologies and promises to deliv...and ease-of-use to the straining,global clinical I...
...Inc., a,pioneer in drug discovery from marine micr... begun in a Phase 1b study evaluating the vascular...th standard chemotherapy,in patients with non-smal...positive outcomes in a Phase 1 single-agent clinic...harmacodynamics (PK/PD) and efficacy of NPI-2358,i...
...ian acceptance of electrophysiology ablation as...lation, according to Millennium Research Group, W...esearch Group,s Global Markets for Atrial Fibrilla...00 electrophysiology (EP) procedures were,performe... procedure,volumes will increase at a compound ann...
Other Biology Technology:Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 2Tourtellotte's New Trident IWR(TM) Eliminates 12-Week Study Setup Lead Time for Clinical Trials 3Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 2Nereus Pharmaceuticals Initiates Clinical Trial of NPI-2358 in Non-Small Cell Lung Cancer Following Encouraging Phase 1 Data 3Electrophysiology Procedures for Atrial Fibrillation Treatment to Grow Over 25% Annually Over the Next Five Years 2
(Date:11/23/2009)...s. November 23, 2009 Applied mathematicians diss...lancifolia ), a characteristic long leaf with a sa...s along the edges. The simple cause of the lily,s ...nding during differential growthwas revealed by us...ibbons. , Haiyi Liang, a postdoctoral student at...
(Date:11/23/2009)...More than 160 participants gathered this week for ... INITIATIVE conference. This year,s topic, "Synthe...rs, and medical researchers to explore the enginee...e emerging field of synthetic biology. , Bonnie ...ceton University and this year,s conference chair,...
(Date:11/23/2009)... only swine vaccine available for the H1N1 virus h...th the virus. The vaccination marks the first time...ith the pandemic flu., Iowa State University,s H... the vaccine this summer and has been shipping pre...nd Illinois for several weeks., The latest vacci...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B 28R 29 49981 1Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B 28R 29 49981 2Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita based Center of Excellence with Global Convenience 28TM 29 12775 1Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita based Center of Excellence with Global Convenience 28TM 29 12775 2Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita based Center of Excellence with Global Convenience 28TM 29 12775 3Migraine Frequency Tied to Stroke Heart Attack Risk 49976 1Migraine Frequency Tied to Stroke Heart Attack Risk 49976 2Migraine Frequency Tied to Stroke Heart Attack Risk 49976 3
...trains of influenza showed genetic differences fro...virus flu shot was found to be effective in preven...ted-virus nasal spray vaccine also prevented illne...determined by laboratory confirmation of flu infec...rlier studies had suggested that the nasal spray, ...
...n to eat their fruit and vegetables. But once kids...ften go the way of Barbie dolls and power rangers.... fruits past adolescence. , Fisetin, a naturally o...and other fruits and vegetables, stimulates signal... researchers at the Salk Institute for Biological ...
...fornia, San Diego (UCSD) School of Medicine ? www.... the world to self-report adverse effects of stati... "This line of research is important because many ...cholesterol are familiar with the benefits of stat...r with the adverse experiences with these drugs th...
Other Biology News:Flu shot effective against drifted influenza, nasal spray vaccine less so 2Flu shot effective against drifted influenza, nasal spray vaccine less so 3A natural chemical found in strawberries boosts memory in healthy mice 2A natural chemical found in strawberries boosts memory in healthy mice 3Patients can report statins' adverse effects on new web site 2
Streptavidin, PE-Cy5.5 conjugated/tagged from eBioscience
Rabbit Anti-p27 Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-Shigella Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Rabbit Anti-Aortic Elastin Polyclonal Antibody, Unconjugated from Abcam
Biology Products: